Health Care

Council on Foreign Relations -
07.23.12
On the Council on Foreign Relations' development blog, the Stanford GSB's Stefanos Zenios and Lyn Denend explore the challenges of bringing high-quality health care to developing economies.
photo of patient and MRI machine
The head of the Permanente Federation says innovation is critical to improving U.S. health care.
photo of MRI
Abbott’s John Capek discusses health care device regulation, transparency, and the critical relationship between physicians and their patients.
Bill Frist
A conversation on health care innovation with former Senate majority leader and surgeon Bill Frist.
Image of chinese father and child waiting for health care
Serial entrepreneur Kewen Jin discusses the rapid growth of China's health care industry and the idea of "innovation by subtraction."
Stefanos Zenios photo
In an online forum, Stefanos Zenios responds to reader questions on innovation in the field.
A program using cell phones to get anti-malaria drugs to the rural spots that need them most is one program that has helped lower deaths from malaria in Africa Silvio Gabriel, an executive with Novartis Pharma, told a Stanford Graduate School of Business audience.

Pages

photo of MRI
Abbott’s John Capek discusses health care device regulation, transparency, and the critical relationship between physicians and their patients.
photo of patient and MRI machine
The head of the Permanente Federation says innovation is critical to improving U.S. health care.
Bill Frist
A conversation on health care innovation with former Senate majority leader and surgeon Bill Frist.
Image of chinese father and child waiting for health care
Serial entrepreneur Kewen Jin discusses the rapid growth of China's health care industry and the idea of "innovation by subtraction."
Stefanos Zenios photo
In an online forum, Stefanos Zenios responds to reader questions on innovation in the field.
A program using cell phones to get anti-malaria drugs to the rural spots that need them most is one program that has helped lower deaths from malaria in Africa Silvio Gabriel, an executive with Novartis Pharma, told a Stanford Graduate School of Business audience.